Gary Fischer
Analyst · Craig-Hallum. Your line is open
Thank you, Leslie. Good afternoon to everyone. Revenue for the third quarter of 2023 was $17.4 million, down from $18.6 million in the second quarter of 2023, and down from $35.2 million in the third quarter of 2022. To break down our Q3 2023 revenue for you by product line, Indium phosphide came in at $4.9 million, reflecting a stabilizing market with modest improvement in data center applications, gallium arsenide was $4.2 million. We're pleased to obtain our first permits to ship gallium arsenide substrates during the quarter and continue to work through that process on behalf of a growing number of our gallium arsenide customers. Germanium substrates were $1.2 million, up from the prior quarter, also reflecting our progress in obtaining permits on behalf of our customers. Finally, revenue from our two consolidated raw material joint venture companies in Q3 was $7.0 million. In the third quarter of 2023, revenue from Asia Pacific was 82%, Europe was 14%, and North America was 4%. The top five customers generated approximately 31% of total revenue and no customers over the 10% level. Non-GAAP gross margin in the third quarter was 11.3%, compared with 9.8% in Q2, and 42.2% in Q3 of 2022. For those who prefer to track results on a GAAP basis, gross margin in the third quarter was 10.7%, compared with 9.2% in Q2, and 42.0% in Q3 of 2022. The primary drivers affecting our corporate gross margin in Q3 were volume, product mix and an improvement in our raw material business gross margin. Beyond the near term, we remain confident that we can get back to the mid-30% range as the environment strengthens through higher overall volume, more favorable product mix, and the benefits of our recycling programs, along with continued efficiency improvements throughout our business. Moving to our operating expenses, with the reduction in overall revenue, we have maintained spending discipline in our operating expenses to align with the current environment. Total non-GAAP operating expense in Q3 was $7.8 million, consistent with our results in Q2 2023, and down from $9.2 million in Q3 of 2022. On a GAAP basis, total operating expenses in Q3 was $8.6 million, consistent with our results in Q2 of 2023, and down from $10.2 million in Q3 of 2022. Our non-GAAP operating income for the third quarter of 2023 was a loss of $5.8 million, compared with the non-GAAP operating loss in Q2 of 2023 of $5.9 million, and the non-GAAP operating profit of $5.6 million in Q3 of 2022. For reference, our GAAP operating line for the third quarter of 2023 was a loss of $6.7 million, compared with an operating loss of $6.8 million in Q2, and an operating profit of $4.6 million in Q3 of 2022. Non-operating other income and expense and other items below the operating line for the third quarter of 2023 was a net gain of $0.9 million. The details can be seen in the P&L included in our press release today. For Q3 2023, we had a non-GAAP net loss of $4.9 million, or $0.12 per share, compared with a non-GAAP net loss of $4.2 million, or $0.10 per share, in the second quarter of 2023. Non-GAAP net income in Q3 2022 was $6.8 million, or $0.16 per share. On a GAAP basis, net loss in Q3 was $5.8 million, or $0.14 per share. By comparison, net loss was $5.1 million, or $0.12 per share, in the second quarter of 2023. GAAP net income in Q3 2022 was $5.8 million, or $0.13 per share. The weighted average basic shares outstanding in Q3 was $42.6 million. Cash, cash equivalents, and investments were $43.6 million as of September 30th. By comparison, at June 30, it was $49.6 million. The reduction in cash was primarily due to net cash generated by operating activities. Although last quarter that was positive in Q3, it was negative this quarter. Depreciation and amortization in the third quarter was $2.2 million and CapEx was about $4 million. Total stock comp was $0.9 million. As I mentioned, net inventory came down by $700,000 to $86.4 million at September 30, 41% of the inventory is raw materials, and WIP is 55%, finished goods makes up only approximately 4%. Okay. This concludes the report on our quarterly financial results. Turning to our plan to list our subsidiary, Tongmei in China, on the STAR Market in Shanghai, we do need to resolve one open item. Morris is in China as we speak and is working on this matter. Although it is moving slower than we expected, we are making progress, and we are confident that Tongmei remains an excellent candidate for a listing and will be approved to proceed. With that, I'll now turn the call over to Dr. Morris Young for a review of our business and markets. Morris, welcome from China.